These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 27587721)

  • 21. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies.
    Darvishian M; Bijlsma MJ; Hak E; van den Heuvel ER
    Lancet Infect Dis; 2014 Dec; 14(12):1228-39. PubMed ID: 25455990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia.
    Carville KS; Grant KA; Sullivan SG; Fielding JE; Lane CR; Franklin L; Druce J; Kelly HA
    Vaccine; 2015 Jan; 33(2):341-5. PubMed ID: 25448093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of inactivated quadrivalent influenza vaccine in the 2015/2016 season as assessed in both a test-negative case-control study design and a traditional case-control study design.
    Kimiya T; Shinjoh M; Anzo M; Takahashi H; Sekiguchi S; Sugaya N; Takahashi T
    Eur J Pediatr; 2018 Jul; 177(7):1009-1017. PubMed ID: 29680993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach.
    Lane CR; Carville KS; Pierse N; Kelly HA
    Vaccine; 2016 Feb; 34(8):1070-6. PubMed ID: 26795366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of 2010/2011 seasonal influenza vaccine in Ireland.
    Barret AS; Donnell JO; O'Hora A; Collins C; Coughlan S; Joyce M; Moran J; Waters A; O'Malley A; Domegan L; O'Flanagan D
    Ir Med J; 2012 Feb; 105(2):39-42. PubMed ID: 22455236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.
    Cowling BJ; Feng S; Finelli L; Steffens A; Fowlkes A
    Vaccine; 2016 Jan; 34(1):61-6. PubMed ID: 26611200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20.
    Baum U; Kulathinal S; Auranen K
    Euro Surveill; 2021 Sep; 26(36):. PubMed ID: 34505568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR).
    Coleman LA; Kieke B; Irving S; Shay DK; Vandermause M; Lindstrom S; Belongia EA
    Vaccine; 2011 Jan; 29(3):387-90. PubMed ID: 21095253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza virus surveillance, vaccine strain selection, and manufacture.
    Stöhr K; Bucher D; Colgate T; Wood J
    Methods Mol Biol; 2012; 865():147-62. PubMed ID: 22528158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias.
    Talbot HK; Nian H; Chen Q; Zhu Y; Edwards KM; Griffin MR
    Vaccine; 2016 Apr; 34(15):1806-9. PubMed ID: 26930368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic principle of population-based cohort study to evaluate influenza vaccine effectiveness among elderly Japanese.
    Hara M; Hirota Y
    Vaccine; 2017 Aug; 35(36):4791-4795. PubMed ID: 28818470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of selection bias on vaccine effectiveness estimates from test-negative studies.
    Jackson ML; Phillips CH; Benoit J; Kiniry E; Madziwa L; Nelson JC; Jackson LA
    Vaccine; 2018 Jan; 36(5):751-757. PubMed ID: 29254838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness.
    Bond HS; Sullivan SG; Cowling BJ
    Epidemiol Infect; 2016 Jun; 144(8):1601-11. PubMed ID: 26732691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid epidemiological and virological assessment.
    Emborg HD; Krause TG; Nielsen L; Thomsen MK; Christiansen CB; Skov MN; Nielsen XC; Weinreich LS; Fischer TK; Rønn J; Trebbien R
    Euro Surveill; 2016; 21(14):. PubMed ID: 27101732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.